Nicholas A.j. Botwood
Head Of R&D, Cmo at Syndax Pharmaceuticals Inc (SNDX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 12SEC | SNDXSyndax Pharmaceuticals Inc | Sell Plan | 34,28060,885 held (−36%) | $18.00 | $617K | -28.3% |
| Jun 12SEC | SNDXSyndax Pharmaceuticals Inc | Sell Plan | 31,23560,885 held (−34%) | $18.14 | $567K | -28.9% |
- Sell
Head Of R&D, Cmo Nicholas A.j. Botwood sold $617K of SNDX at $18.00 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.
- Sell
Head Of R&D, Cmo Nicholas A.j. Botwood sold $567K of SNDX at $18.14 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.